Publication:
Trastuzumab deruxtecan in her2-low breast cancer

Simple item page
dc.contributor.coauthorÖzbalak, Murat
dc.contributor.departmentN/A
dc.contributor.kuauthorFerhanoğlu, Ahmet Burhan
dc.contributor.kuauthorBirtaş Ateşoğlu, Elif
dc.contributor.kuprofileFaculty Member
dc.contributor.kuprofileN/A
dc.contributor.schoolcollegeinstituteSchool of Medicine
dc.contributor.schoolcollegeinstituteSchool of Medicine
dc.contributor.yokid18320
dc.contributor.yokidN/A
dc.date.accessioned2024-11-09T23:26:44Z
dc.date.issued2022
dc.description.abstractN/A
dc.description.indexedbyWoS
dc.description.issue12
dc.description.openaccessNO
dc.description.publisherscopeInternational
dc.description.volume387
dc.identifier.doiN/A
dc.identifier.eissn1533-4406
dc.identifier.issn0028-4793
dc.identifier.quartileQ1
dc.identifier.urihttps://hdl.handle.net/20.500.14288/11585
dc.identifier.wos865461700017
dc.keywordsN/A
dc.languageEnglish
dc.publisherMassachusetts Medical Soc
dc.sourceNew England Journal of Medicine
dc.subjectMedicine
dc.subjectGeneral
dc.subjectInternal
dc.titleTrastuzumab deruxtecan in her2-low breast cancer
dc.typeLetter
dspace.entity.typePublication
local.contributor.authorid0000-0002-4257-549X
local.contributor.authoridN/A
local.contributor.kuauthorFerhanoğlu, Ahmet Burhan
local.contributor.kuauthorBirtaş Ateşoğlu, Elif

Files

Collections

Publications without Fulltext